Presentations -

Don’t miss out on the latest stem cell presentations from all over the UK and beyond. Discover upcoming presentations from around the world by browsing our calendar below. Whether you want to attend a lab tour in London or a find out more about regenerative medicine, check back here often to discover what presentations are happening where and when.

Presentations
Singapore | 16 November 2017

“Celixir's Phase IIb/ Phase III Regenerative Medicine Clinical Trials.”

London | 10 May 2017

“The differences in culture of institutional biotech investors in Europe versus the US, and how that impacts the ability of individual biotechs to grow and commercialise.”

Florence | 18 to 21 October 2016

Presentation by Celixir :

  • Fixing the So-called Unfixable: Regenerating Untreatable Fixed Myocardial Scar in Heart Failure Patients; A. Reginald, S. Sultan, L. Chapman, M. Evans, K, P. Antonitsis, S. Westaby and K. Anastasiadis

Celixir Posters :

  • Immunomodulatory Progenitor Cells: A Novel And Safe Allogeneic Therapy For Patients With Ischaemic Cardiomyopathy Undergoing Coronary Artery Bypass Grafting; S. Sultan, A. Reginald, L. Chapman, M. Evans, K, P. Antonitsis, S. Westaby and K. Anastasiadis
  • Tendoncel Phase II Placebo Controlled Randomized Clinical Trial Results For A Novel Allogeneic Regenerative Topical Medicine In Treatment Of Chronic Tendon Injury; A. Reginald, S. Sultan, A. Mousiadou, L. Chapman, M. Evans & G. Panagiotis
Germany | 28 September 2016

“Introduction to cell & gene therapy” and “Topic Based Partnering”

Helsinki, Finland | 17-20 September 2015

Celixir studies presented:

  • ESGCT 2015 Reginald et al. Tendoncel™ Phase II Placebo controlled Randomized Clinical Trial results of a novel allogeneic regenerative topical medicine in treatment of Chronic Tendon injury
  • ESGCT 2015 Sultan et al. Isolation of immunomodulatory progenitor cells of mesodermal lineage
  • ESGCT 2015 Sultan et al. Immunomodulatory progenitor cells- a novel allogeneic therapy for patients with ischaemic cardiomyopathy undergoing coronary artery bypass grafting
London | August 10-12, 2015

Celixir studies presented:

  • CGT 2015 Reginald et al. A Double Blind Randomised Placebo Controlled Phase IIb Clinical Trial to Study the Efficacy and Safety of Tendoncel™ in Lateral Epicondylitis
Stockholm, Sweden | 24th-27th June 2015

Celixir studies presented:

  • ISSCR 2015 Sultan et al. Immunomodulatory Progenitor Cells A Novel Allogeneic Therapy for Patients with Ischaemic Cardiomyopathy undergoing CABG
  • ISSCR 2015 Sultan et al. Isolation of Immunomodulatory Progenitor Cells A Novel and Distinct Mesodermal Progenitor Cell
  • ISSCR 2015 Sultan et al. Tendoncel™ Phase II Placebo controlled Randomized Clinical Trial results of a novel allogeneic regenerative topical medicine in treatment of Chronic Tendon injury
Strathclyde, Glasgow | 9th-11th June 2015

Celixir studies presented:

  • BSGCT 2015 Sultan et al. Isolation of iMP Cells A Novel and Distinct Mesodermal Progenitor Cell
Cambridge | 22-24 April 2015

Celixir studies presented:

  • The Biology of Regenerative Medicines 2015 Sultan et al. Isolation of iMP Cells of Mesodermal Lineage From Healthy Peripheral Blood
Istanbul, Turkey | 26th-29th March 2015

Celixir studies presented:

  • ESCVS 2015 Roberts et al. Myocardial Regeneration with Cell Therapy – Heartcel™
Twitter Feed